Safety of SCH 527123 in Subjects With Neutrophilic Asthma.

Trial Profile

Safety of SCH 527123 in Subjects With Neutrophilic Asthma.

Completed
Phase of Trial: Phase II

Latest Information Update: 12 Apr 2017

At a glance

  • Drugs Navarixin (Primary)
  • Indications Asthma
  • Focus Therapeutic Use
  • Sponsors Merck
  • Most Recent Events

    • 01 Jul 2012 Results published in Clinical and Experimental Allergy.
    • 28 Apr 2012 Additional trial location added as reported by European Clinical Trials Database.
    • 19 May 2010 Results will be presented at the 106th International Conference of the American Thoracic Society.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top